Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000924456 | SCV001069970 | benign | X-linked severe combined immunodeficiency | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029499 | SCV004886850 | uncertain significance | Inborn genetic diseases | 2021-08-30 | criteria provided, single submitter | clinical testing | The c.86C>T (p.T29M) alteration is located in exon 1 (coding exon 1) of the IL2RG gene. This alteration results from a C to T substitution at nucleotide position 86, causing the threonine (T) at amino acid position 29 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000924456 | SCV002087237 | likely benign | X-linked severe combined immunodeficiency | 2020-11-06 | no assertion criteria provided | clinical testing |